Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-May-24 6:07 PM View:  | Ligand Pharmaceuticals Inc. (LGND) | 30-Apr-24 | Option Exercise | 2,406 | $52.30 | $125,834.00 | 2% 131.04K to 133.45K | |
| 06-Mar-24 10:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 05-Mar-24 | Option Exercise | 2,893 | $39.35 | $113,840.00 | 2% 128.15K to 131.04K | |
| 13-Jun-23 10:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 09-Jun-23 | Grant | 1,142 | -- | -- | < 1% 127.01K to 128.15K | |
| 05-May-23 8:16 PM View: | Orchestra Biomed Holdings, ... (OBIO) | 12-Apr-23 | Option Exercise | 11,246 | -- | -- | 22% 51.74K to 62.98K | |
| 30-Jan-23 9:31 PM View: | Orchestra Biomed Holdings, ... (OBIO) | 26-Jan-23 | Grant | 51,738 | -- | -- | 100% 0 to 51.74K | |
| 13-Jun-22 6:47 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 10-Jun-22 | Grant | 1,004 | -- | -- | < 1% 125.28K to 126.29K | |
| 07-Jun-21 9:39 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 04-Jun-21 | Grant | 630 | -- | -- | < 1% 124.65K to 125.28K | |
| 12-Jun-20 6:35 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 10-Jun-20 | Grant | 831 | -- | -- | < 1% 123.82K to 124.65K | |
| 04-Sep-19 7:30 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 03-Sep-19 | Market Purchase (Planned) | 750 | $87.01 | $65,257.50 | < 1% 123.07K to 123.82K | 50% |
| 06-Aug-19 5:18 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 05-Aug-19 | Market Purchase (Planned) | 746 | $90.01 | $67,146.00 | < 1% 122.33K to 123.07K | 45% |
| 31-Jul-19 6:50 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 31-Jul-19 | Market Purchase (Planned) | 754 | $93.00 | $70,121.50 | < 1% 121.57K to 122.33K | 40% |
| 31-Jul-19 6:50 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Jul-19 | Market Purchase (Planned) | 3,000 | $100.22 | $300,663.00 | 3% 118.57K to 121.57K | 30% |
| 31-Jul-19 6:50 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 29-Jul-19 | Market Purchase (Planned) | 250 | $106.01 | $26,502.50 | < 1% 118.32K to 118.57K | 23% |
| 18-Jul-19 7:38 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 16-Jul-19 | Market Purchase | 302 | $5.44 | $1,642.88 | 9% 3.5K to 3.8K | 6% |
| 15-Jul-19 4:32 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 12-Jul-19 | Market Purchase | 3,400 | $5.68 | $19,324.00 | 3400% 100 to 3.5K | 1% |
| 15-Jul-19 4:32 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 11-Jul-19 | Market Purchase | 100 | $5.71 | $571.00 | 100% 0 to 100 | < 1% |
| 12-Jun-19 6:51 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 11-Jun-19 | Market Purchase (Planned) | 250 | $107.01 | $26,752.50 | < 1% 118.07K to 118.32K | 22% |
| 07-Jun-19 6:55 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 06-Jun-19 | Grant | 835 | -- | -- | < 1% 117.24K to 118.07K | |
| 31-May-19 6:27 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 31-May-19 | Market Purchase (Planned) | 500 | $108.51 | $54,255.00 | < 1% 116.74K to 117.24K | 20% |
| 31-May-19 6:27 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-May-19 | Market Purchase (Planned) | 250 | $110.01 | $27,502.50 | < 1% 116.49K to 116.74K | 18% |
| 31-May-19 6:27 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 29-May-19 | Market Purchase (Planned) | 250 | $111.01 | $27,752.50 | < 1% 116.24K to 116.49K | 17% |
| 22-May-19 5:36 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 20-May-19 | Market Purchase (Planned) | 250 | $112.01 | $28,002.50 | < 1% 115.99K to 116.24K | 16% |
| 16-May-19 3:54 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 14-May-19 | Market Purchase (Planned) | 250 | $112.51 | $28,127.50 | < 1% 115.74K to 115.99K | 16% |
| 15-Mar-19 1:59 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 13-Mar-19 | Market Purchase | 202 | $112.51 | $22,727.00 | < 1% 115.53K to 115.74K | 16% |
| 17-Aug-18 7:38 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 17-Aug-18 | Market Sale | 26,862 | $241.81 | $6,495,560.00 | (19%) 142.4K to 115.53K | 46% |
| 17-Aug-18 7:38 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 16-Aug-18 | Market Sale | 1,080 | $245.00 | $264,600.00 | (< 1%) 143.48K to 142.4K | 47% |
| 21-Jun-18 4:42 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 19-Jun-18 | Grant | 493 | -- | -- | < 1% 142.98K to 143.48K | |
| 09-Mar-18 6:28 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 09-Mar-18 | Market Sale | 4,000 | $176.48 | $705,899.00 | (3%) 146.98K to 142.98K | 26% |
| 09-Mar-18 6:28 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 08-Mar-18 | Market Sale | 3,500 | $174.88 | $612,095.00 | (2%) 150.48K to 146.98K | 26% |
| 27-Feb-18 6:40 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 26-Feb-18 | Gift | 1,000 | -- | -- | (< 1%) 151.48K to 150.48K | |
| 27-Feb-18 6:40 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 23-Feb-18 | Market Sale | 3,417 | $155.00 | $529,635.00 | (2%) 154.9K to 151.48K | 16% |
| 20-Nov-17 5:01 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 17-Nov-17 | Market Sale | 24,400 | $140.22 | $3,421,370.00 | (14%) 179.3K to 154.9K | 7% |
| 25-Aug-17 5:36 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 23-Aug-17 | Market Sale | 2,000 | $127.99 | $255,980.00 | (1%) 181.3K to 179.3K | (2%) |
| 26-May-17 8:15 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 25-May-17 | Grant | 666 | -- | -- | < 1% 180.63K to 181.3K | |
| 24-May-17 6:07 AM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 23-May-17 | Market Sale | 104,176 | $1.41 | $146,878.00 | (87%) 119.18K to 15.0K | 98% |
| 24-May-17 6:07 AM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 22-May-17 | Market Sale | 233,468 | $1.42 | $332,365.00 | (66%) 352.64K to 119.18K | 98% |
| 24-May-17 6:07 AM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 19-May-17 | Market Sale | 51,041 | $1.56 | $79,557.60 | (13%) 403.69K to 352.64K | 98% |
| 17-May-17 5:43 PM View: | QLT Inc. (NVLNF) | 15-May-17 | Market Purchase | 361 | $8.95 | $3,230.95 | < 1% 392.37K to 392.73K | |
| 12-May-17 8:06 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 12-May-17 | Market Sale | 14,582 | $111.87 | $1,631,330.00 | (7%) 195.22K to 180.63K | (16%) |
| 12-May-17 9:50 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 7,500 | -- | -- | 2% 350.72K to 358.22K | |
| 12-May-17 8:06 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 11-May-17 | Market Sale | 22,665 | $110.04 | $2,494,020.00 | (10%) 217.88K to 195.22K | (18%) |
| 28-Feb-17 10:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Feb-17 | Market Sale | 7,000 | $107.58 | $753,060.00 | (3%) 224.88K to 217.88K | (21%) |
| 28-Feb-17 10:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 27-Feb-17 | Market Sale | 25,000 | $106.00 | $2,650,000.00 | (10%) 249.88K to 224.88K | (23%) |
| 01-Dec-16 4:06 PM View: | QLT Inc. (NVLNF) | 29-Nov-16 | Grant | 1,136,360 | $1.76 | $2,000,000.00 | 212% 535.48K to 1.67M | |
| 01-Dec-16 4:06 PM View: | QLT Inc. (NVLNF) | 29-Nov-16 | Grant | 290,024 | -- | -- | 17% 1.67M to 1.96M | |
| 25-Nov-16 5:58 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 25-Nov-16 | Market Sale | 3,478 | $106.96 | $372,007.00 | (1%) 253.36K to 249.88K | (22%) |
| 25-Nov-16 5:58 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 22-Nov-16 | Market Sale | 15,001 | $107.40 | $1,611,070.00 | (6%) 268.36K to 253.36K | (21%) |
| 18-Nov-16 4:48 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 18-Nov-16 | Market Sale | 5,000 | $105.00 | $525,000.00 | (2%) 273.36K to 268.36K | (24%) |
| 18-Nov-16 4:48 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 16-Nov-16 | Market Sale | 1,330 | $106.33 | $141,419.00 | (< 1%) 274.69K to 273.36K | (22%) |
| 25-Apr-17 4:30 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 16-Sep-16 | Market Purchase | 295,929 | $5.86 | $1,732,660.00 | 540% 54.79K to 350.72K | (100%) |